Cargando…
Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform
BACKGROUND: Current drug regimens for cutaneous leishmaniasis (CL) include toxic systemic therapies such as amphotericin B (AB) and pentavalent antimonials. Fluconazole (FZ) is a well-tolerated potential oral alternative for the management CL. To date, few objective data exist to guide clinical deci...
Autores principales: | Kariyawasam, Ruwandi, Challa, Priyanka, Lau, Rachel, Boggild, Andrea K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615197/ https://www.ncbi.nlm.nih.gov/pubmed/31286895 http://dx.doi.org/10.1186/s12879-019-4237-3 |
Ejemplares similares
-
Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation
por: Siopi, Maria, et al.
Publicado: (2023) -
Identification of Candida species and susceptibility testing with Sensititre YeastOne microdilution panel to 9 antifungal agents
por: Kucukates, Emine, et al.
Publicado: (2016) -
Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between Sensititre(TM) YeastOne(TM) and MIC Test Strip
por: Lo Cascio, Giuliana, et al.
Publicado: (2022) -
Comparison of Two Commercial Colorimetric Broth Microdilution Tests for Candida Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM
por: Philips, Sophie, et al.
Publicado: (2021) -
Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3 reference method to determine the activity of antifungal agents against clinical isolates of Candida spp.
por: ALTINBAŞ, Rabiye, et al.
Publicado: (2020)